SIM
ARKG icon

Seaview Investment Managers’s ARK Genomic Revolution ETF ARKG Stock Holding History

Seaview Investment Managers’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-14,049
Closed -$1.3M – 91
2021
Q2 		$1.3M Buy
14,049
+4,485
+47% +$381K 0.66% 39
2021
Q1 		$849K Buy
9,564
+9,534
+31,780% +$946K 0.62% 49
2020
Q4 		$2K Buy
+30
New +$2.39K ﹤0.01% 136

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Seaview Investment Managers's ARKG Position: Q3 2021 in Review

Seaview Investment Managers sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2021, closing a stake of 14,049 shares — an estimated $1.3M sold.

Seaview Investment Managers first reported a position in ARKG in Q4 2020 and held it in 3 quarters. The position peaked at $1.3M in Q2 2021. 470 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.

  • Seaview Investment Managers reported no remaining ARK Genomic Revolution ETF position as of Q3 2021 after selling out during the quarter.
  • Seaview Investment Managers sold 14,049 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $1.3M.
  • Seaview Investment Managers first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 3 quarters.
  • Seaview Investment Managers's ARK Genomic Revolution ETF position peaked at $1.3M in Q2 2021.
  • 470 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.

Based on Seaview Investment Managers's 13F filing for Q3 2021, filed 27 Oct 2021.